
Callan JMB Inc. Faces Nasdaq Delisting Over Equity Deficiency
Callan JMB Inc. has received a determination from Nasdaq that it has failed to meet the minimum stockholders' equity requirement for continued listing. The company was previously notified of a deficiency and granted an extension until October 5, 2026. As capital raising initiatives were unsuccessful, Nasdaq has determined non-compliance. Trading suspension and delisting are set for October 21, 2026, unless an appeal is filed by October 19, 2026. The company has requested a hearing to appeal this determination and intends to demonstrate compliance.
Key Highlights
- Callan JMB Inc. received a deficiency letter from Nasdaq for failing to meet the Stockholders' Equity Requirement.
- The company was granted an extension until October 5, 2026, to regain compliance.
- On October 12, 2026, Nasdaq determined the company did not meet the extension terms.
- Trading suspension and delisting are scheduled for October 21, 2026, unless an appeal is requested by October 19, 2026.
- Callan JMB Inc. has requested a hearing before a Nasdaq Hearings Panel to appeal the determination.
Price Impact
More from CJMB
Callan JMB Inc. Reports Increased Net Loss and Decreased Revenue for Nine Months Ended Sep 30, 2026
Callan JMB Raises $1.5M in Private Placement; CEO and Insiders Invest
Callan JMB supports Chicago's 2026 Lollapalooza preparedness